AIMS: The aims of this study were to assess the sensitivity of the International Behavioural Variant FTD Criteria Consortium (FTDC) revised criteria of behavioural variant frontotemporal dementia (bvFTD) in a pathological cohort and to determine their predictive values in a clinical context suggestive of bvFTD. In addition, the study aimed to assess the influence of the age at onset and underlying pathology in the clinicopathological correlations. METHODS: Retrospective, blinded review of the clinical and neuropathological data from the Neurological Tissue Bank of the Biobank Hospital Clinic-IDIBAPS, Barcelona (Spain) was conducted, assessing the fulfilment of the diagnostic criteria on a case-by-case basis. Two separate nonexclusive cohorts were selected: Cohort 1 (n = 58) subjects with pathological diagnosis of frontotemporal lobar degeneration (FTLD) and Cohort 2 (n = 66) subjects with the premortem diagnosis of bvFTD. RESULTS: The FTDC criteria reached a sensitivity of 93% for possible and 80% for probable bvFTD. Early-onset cases displayed significantly more disinhibition, loss of empathy and compulsive behaviour with respect to late-onset bvFTD, leading to a slightly higher sensitivity of the diagnostic criteria (97% vs. 91%). There were no differences in the diagnostic performance between tau-positive and tau-negative cases. In subjects clinically diagnosed as bvFTD, a 'possible bvFTD' diagnosis reached a positive predictive value for FTLD pathology of 90%, irrespective of underlying proteinopathy. False-positive clinical diagnoses were mainly Alzheimer's disease. These cases were significantly older, had less family history of dementia and had a predominantly apathetic clinical picture. CONCLUSIONS: The revised bvFTD criteria present good sensitivity and positive predictive value in both early- and late-onset cases and regardless of the underlying FTLD pathology.
AIMS: The aims of this study were to assess the sensitivity of the International Behavioural Variant FTD Criteria Consortium (FTDC) revised criteria of behavioural variant frontotemporal dementia (bvFTD) in a pathological cohort and to determine their predictive values in a clinical context suggestive of bvFTD. In addition, the study aimed to assess the influence of the age at onset and underlying pathology in the clinicopathological correlations. METHODS: Retrospective, blinded review of the clinical and neuropathological data from the Neurological Tissue Bank of the Biobank Hospital Clinic-IDIBAPS, Barcelona (Spain) was conducted, assessing the fulfilment of the diagnostic criteria on a case-by-case basis. Two separate nonexclusive cohorts were selected: Cohort 1 (n = 58) subjects with pathological diagnosis of frontotemporal lobar degeneration (FTLD) and Cohort 2 (n = 66) subjects with the premortem diagnosis of bvFTD. RESULTS: The FTDC criteria reached a sensitivity of 93% for possible and 80% for probable bvFTD. Early-onset cases displayed significantly more disinhibition, loss of empathy and compulsive behaviour with respect to late-onset bvFTD, leading to a slightly higher sensitivity of the diagnostic criteria (97% vs. 91%). There were no differences in the diagnostic performance between tau-positive and tau-negative cases. In subjects clinically diagnosed as bvFTD, a 'possible bvFTD' diagnosis reached a positive predictive value for FTLD pathology of 90%, irrespective of underlying proteinopathy. False-positive clinical diagnoses were mainly Alzheimer's disease. These cases were significantly older, had less family history of dementia and had a predominantly apathetic clinical picture. CONCLUSIONS: The revised bvFTD criteria present good sensitivity and positive predictive value in both early- and late-onset cases and regardless of the underlying FTLD pathology.
Authors: Ignacio Illán-Gala; Victor Montal; Sergi Borrego-Écija; Eduard Vilaplana; Jordi Pegueroles; Daniel Alcolea; Belén Sánchez-Saudinós; Jordi Clarimón; Janina Turón-Sans; Nuria Bargalló; Sofía González-Ortiz; Howard J Rosen; Maria Luisa Gorno-Tempini; Bruce L Miller; Albert Lladó; Ricard Rojas-García; Rafael Blesa; Raquel Sánchez-Valle; Alberto Lleó; Juan Fortea Journal: Brain Date: 2019-04-01 Impact factor: 13.501
Authors: Aida Kamalian; Tina Khodadadifar; Amin Saberi; Maryam Masoudi; Julia A Camilleri; Claudia R Eickhoff; Mojtaba Zarei; Lorenzo Pasquini; Angela R Laird; Peter T Fox; Simon B Eickhoff; Masoud Tahmasian Journal: Alzheimers Dement (Amst) Date: 2022-05-29
Authors: Geidy E Serrano; Anthony Intorcia; Jeremiah Carew; Glenn Chiarolanza; Jose A Hidalgo; Lucia I Sue; Brittany N Dugger; Megan Saxon-LaBelle; Jessica Filon; Alex Scroggins; Joel Pullen; Brandon E Fornwalt; Sarah Scott; Marwan N Sabbagh; Charles H Adler; Haruhiko Akiyama; Thomas G Beach Journal: J Neuropathol Exp Neurol Date: 2015-09 Impact factor: 3.685
Authors: Ignacio Illán-Gala; Neus Falgàs; Adit Friedberg; Sheila Castro-Suárez; Ophir Keret; Nicole Rogers; Didem Oz; Salvatore Nigro; Andrea Quattrone; Aldo Quattrone; Amy Wolf; Kyan Younes; Miguel Santos-Santos; Sergi Borrego-Écija; Yann Cobigo; Oriol Dols-Icardo; Albert Lladó; Raquel Sánchez-Valle; Jordi Clarimon; Rafael Blesa; Daniel Alcolea; Juan Fortea; Alberto Lleó; Lea T Grinberg; Salvatore Spina; Joel H Kramer; Gil D Rabinovici; Adam Boxer; Maria Luisa Gorno Tempini; Bruce L Miller; William W Seeley; Howard J Rosen; David C Perry Journal: JAMA Netw Open Date: 2021-03-01
Authors: Antti Cajanus; Anette Hall; Juha Koikkalainen; Eino Solje; Antti Tolonen; Timo Urhemaa; Yawu Liu; Ramona M Haanpää; Päivi Hartikainen; Seppo Helisalmi; Ville Korhonen; Daniel Rueckert; Steen Hasselbalch; Gunhild Waldemar; Patrizia Mecocci; Ritva Vanninen; Mark van Gils; Hilkka Soininen; Jyrki Lötjönen; Anne M Remes Journal: Dement Geriatr Cogn Dis Extra Date: 2018-02-23